Helicobacter pylori eradication: equivalence trials and the optimal duration of therapy
- PMID: 16144122
- DOI: 10.1111/j.1572-0241.2005.50615.x
Helicobacter pylori eradication: equivalence trials and the optimal duration of therapy
Abstract
Equivalence trials are gaining popularity and seek to compare the efficacy of two different types of treatment. The design of these trials requires careful consideration of clinical, statistical, and regulatory concerns. We discuss the importance and key factors relevant to equivalence trials.
Comment on
-
Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.Am J Gastroenterol. 2005 Aug;100(8):1696-701. doi: 10.1111/j.1572-0241.2005.50019.x. Am J Gastroenterol. 2005. PMID: 16086704 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
